Immunotech Laboratories, Inc. is a drug development company. The company is headquartered in Glendale, California and currently employs 4 full-time employees. The company went IPO on 2002-01-07. The firm is also focused on the commercialization of its proprietary proteins known as Irreversible Pepsin Fraction (IPF) ITV-1 for the treatment of debilitating infectious diseases, such as human immunodeficiency virus (HIV) and Hepatitis Type C.
Follow-Up Questions
IMMB 股票的价格表现如何？
IMMB 的当前价格为 $0.0001，在上个交易日 decreased 了 0%。
Immunotech Laboratories Inc 的主要业务主题或行业是什么？
Immunotech Laboratories Inc 属于 Biotechnology 行业，该板块是 Health Care
